Radiopharm Theranostics (ASX:RAD) has the ambition to become a recognised leader in the development of radiopharmaceutical products for both diagnostic and therapeutic uses in areas of high unmet medical needs.
-
Our patients come first
-
We believe in the power of disruptive innovation
-
We are science and data driven
-
We emphasise teamwork – two heads are better than one
-
We value relationships which are honest, collaborative, mutually respectful and which result in a win-win for all
-
When we fail, we don’t lose the lesson
-
We believe in fair play
-
Our partnerships with our physicians, researchers and medical institutions are essential to our success
-
We strive to create a culture of integrity, that is inclusive, and a fun place to work
-
We will aim to protect and enhance our investors’ capital
Latest Media Releases
29/02/2024 09:20:00
-- First Pancreatic Cancer participant dosed at the Montefiore Medical Center, New York, USA
-- Phase I study of 9 participants is designed to assess the safety and dosimetry of RAD 301
-- A total…
Latest News
Market Reports /
by Peter Milios -
A year ago
09 May 2023 - At the closing bell, the S&P/ASX 200 was 0.17 per cent lower at 7,264.10, with real estate stocks weighing down the market.
Market Reports /
by Peter Milios -
A year ago
09 May 2023 - Australia's retail sales volume in the March quarter declined by 0.6%, in line with expectations, marking the second consecutive quarterly decrease, attributed to ong…
Interviews /
by Tim McGowen -
A year ago
17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an upd…
Market Reports /
by Peter Milios -
A year ago
14 Feb 2023 - On the back of gains from Communication Services, Information Technology and Healthcare, at noon, the S&P/ASX 200 is 0.40% higher at 7,447.3.
Market Reports /
by Peter Milios -
A year ago
31 Jan 2023 - Australian shares fluctuated on Tuesday with a 0.4 per cent gain and later 0.2 per cent loss. Consumer stocks led the gains, up 2.3 per cent, while tech stocks weighe…
Market Reports /
by Peter Milios -
2 years ago
22 Nov 2022 - China has reported its first COVID death in six months, sparking up the likelihood of harsher lockdowns. Interestingly, the ASX has disregarded this information, clos…
Interviews /
by Lauren Hayes -
2 years ago
22 Nov 2022 - Radiopharm Theranostics Limited (ASX:RAD) Managing Director and CEO Riccardo Canevari discusses the progress of the company's brain, lung and prostate cancer therapie…
Market Reports /
by Peter Milios -
2 years ago
22 Nov 2022 - The Treasury is expected to release a discussion paper today on the BNPL sector. The paper is likely to outline that Australia’s current buy now, pay later providers …
Market Reports /
by Peter Milios -
2 years ago
26 Oct 2022 - CPI data from the September quarter has sharply exceeded estimates. As such, multiple banks have made predictions for the next rate rise.
Market Reports /
by Lauren Hayes -
2 years ago
26 Oct 2022 - The S&P/ASX 200 posted gains this morning as sentiment from Wall Street overnight improved over the Fed potentially turning less aggressive, combined with a decline i…
Interviews /
by Tim McGowen -
2 years ago
20 Sep 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the FDA's award of orphan status and rare paediatric disease designati…
Market Reports /
by Paul Sanger -
2 years ago
09 Sep 2022 - Australian shares are on track to end the week higher after Wall Street made gains overnight. The ASX held a minute's silence at 11am to mark the death of Queen Eliza…
Interviews /
by Melissa Darmawan -
2 years ago
07 Jul 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's portfolio of therapies.
Market Reports /
by Lauren Evans -
2 years ago
01 Jul 2022 - The Australian sharemarket faded into the close, weighed down by US equity futures in a risk-off afternoon. The greenback rose against the Australian dollar, which h…
Company News /
by Melissa Darmawan -
2 years ago
01 Jul 2022 - Global oncology provider GenesisCare has extended its agreement with biotech company Radiopharm Theranostics (ASX:RAD) to support a second clinical trial in Australia…
Market Reports /
by Melissa Darmawan -
2 years ago
21 Jun 2022 - Australian shares snapped a 7-day losing streak led by resource and financial stocks amid the US futures pointing to a rise as Wall Street looks to resume trade after…
Market Reports /
by Melissa Darmawan -
2 years ago
21 Jun 2022 - The ASX is set to snap a 7-day losing streak as investors were relieved that RBA governor Philip Lowe doesn’t see a local recession coming.
